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SYMPOSIUM
LEGAL AND ETHICAL ISSUES OF
PHYSICIAN PRESCRIPTION AND
PHARMACY SALE OF SYRINGES
TO PATIENTS WHO INJECT
ILLEGAL DRUGS
INTRODUCTION: ASK, TELL, HELP
TO STATE THE OBVIOUS, our physicians matter to our
health. They diagnose and treat our ills, and can help us identify
and change behaviors that put our health at risk. Doctors can't
make us eat better or smoke less, but study after study shows
that they can help patients live healthier just by showing interest
and offering advice and information. At a social level, physi-
cians can play an important role as patient advocates for better
health policies.
Drug users often have doctors or see doctors, and need their
help. Drug use itself is a significant health issue. Although some
drug users can manage even long-term use of powerful drugs
like heroin and cocaine, for many others drug use is a destruc-
tive, chronic illness. All injection drug users face the risk of
HIV, hepatitis, serious bacterial infections, and overdose. The
medical needs of people who use drugs have been poorly served
in a "war on drugs" focused on punishment.
Too often, drug users don't get the help they need from
their doctors. Between the stigma of drug use and the social and
legal complexities of our national response to the phenomenon,
drug users and their doctors have tacitly applied a "Don't Ask,
Don't Tell" policy in the medical encounter. As a result, drug-
injecting patients are not necessarily identified as at risk for in-
jection-related diseases, nor do physicians use their influence to
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help patients take better care of themselves by getting treatment
or using drugs more safely.
The articles in this symposium address physician prescrip-
tion of sterile needles and syringes as a means of improving the
health of drug users and others whose health may indirectly be
placed at risk by injection-related disease. Burnis, Ng, and Lurie
review state syringe and medical and pharmacy practice laws
and conclude that it is legal in most states for physicians to pre-
scribe syringes, and for pharmacists to fill the prescriptions.
Abrahamson finds no legal impediments in federal law, while
Mehlman concludes that the intervention would raise no un-
usual malpractice liability. Lazzarini's ethical analysis likewise
comes to the conclusion that ethics support the practice.
Prescribing needles can help overcome the most immediate
source of disease risk for injection drug users: the reuse and
sharing of needles arising from the users' inability to purchase
new, sterile ones. This is important, and may complement nee-
dle exchange and deregulated pharmacy sales as a means of
getting needles to those who need them to avoid transmitting or
acquiring HIV or hepatitis. But as Rich and colleagues recount
in their review of the nation's first syringe prescribing clinic,
the most important result of the intervention may be the pro-
found change in the doctor-patient relationship it creates. Dr.
Rich found that having drug use out in the open, as it necessar-
ily must be when the physician is offering to prescribe syringes,
put an end to "Don't Ask, Don't Tell" in his clinic. Patients who
had concealed their drug use for years now sought his advice,
received the care they needed, and assessed their need for drug
treatment. Formal evaluation will eventually provide some ob-
jective data on whether eliminating stigma and dealing candidly
with drug use lead to better health outcomes, but Dr. Rich's ac-
count leaves no doubt that offering to prescribe syringes
changed his relationships with his patients for the better.
If prescribing syringes makes for a better physician-patient
relationship, it must be because the physician changes at least as
much as the drug user. Physicians generally are uncomfortable
about discussing drug use with patients, and unsure about how
to intervene when they detect it. These factors can be overcome
with reflection and a little study. The idea of prescribing sy-
ringes is in this light less an end than a means to encourage
physicians to take more responsibility for addressing drug abuse
among their patients.
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And not just in their offices. The nation's drug policies are
sadly out of tune with the needs of public health and people sick
with drug addiction. Physicians have played a role in articulat-
ing a more therapeutic approach to drug use, but more physician
voices are needed. Writing a needle prescription for a patient
who injects drugs and cannot or will not enter drug treatment is
a small but decisive step on the journey to a world in which
people with drug problems are cured, not incarcerated.
The syringe prescribing project was a group effort, and
thanks are owed to many. The authors acknowledge funding and
research support in their various articles. As a group, we are
grateful to Dean Robert Reinstein, Deborah Feldman, Dorothy
Lee, and the faculty and staff of Temple University's Beasley
School of Law, who supported the project in ways too numerous
to enumerate. We thank Professor Maxwell Mehlman and the
staff of this journal for their unstinting efforts to bring these ar-
ticles to press in a timely fashion. Jane Silver of the American
Foundation for AIDS Research, and the AIDS Coordinating
Committee of the American Bar Association, under the chair-
manship of Bob Stein, offered very helpful feedback on the
project at various stages. Dr. Steve Jones and Jennifer Taussig
at the Centers for Disease Control and Prevention were of
enormous help to lawyers trying to understand the complexities
of the public health science underlying the analysis, as were
Kim Blankenship, Sarah Bray, Robert Heimer, and Kaveh
Khoshnood at the Center for Interdisciplinary Research on
AIDS at Yale. Finally, the project could not have been under-
taken without a grant from the Substance Abuse Policy Re-
search Program of the Robert Wood Johnson Foundation. All
these people and organizations have helped us frame and an-
swer the medical and legal questions surrounding syringe pre-
scription, but the responsibility for the conclusions expressed in
the following articles is entirely the authors', and should not be
attributed to any of those upon whose assistance we drew.
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